NASDAQ$BTTC

Black Titan Corp · Q4 2012 earnings

Q4 2012 earnings · · Investor relations

Headline financials

Total Revenue

$3.26M

Previous: $1.41M+130.6%
EPS (adj)

-$3.18

Previous: -$7.81+59.2%
Net Income

-$279K

Previous: -$2.9M+90.4%
Operating Income

-$441K

Previous: -$766K+42.4%
Gross Profit

$686K

Previous: $1.41M-51.5%
R&D Expense

$2.57M

No prior period

Revenue & EPS history

Titan Pharmaceuticals · Revenue · Quarterly

$3.26M

Q4 2012+130.6%vs Q4 2011
Beat estimate in 1 of 1 quarters(100%)
ActualEstimate

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro